Metoclopramide/sodium chloride

Product description：(S)-SNAP5114 is a selective GABA transport inhibitor, with IC50 values of 5 μM and 21 μM for hGAT-3 and rGAT-2, respectively. (S)-SNAP5114 is an anticonvulsant drug.

Product description：(S)-SNAP5114 is a selective GABA transport inhibitor, with IC50 values of 5 μM and 21 μM for hGAT-3 and rGAT-2, respectively. (S)-SNAP5114 is an anticonvulsant drug.

1000 ppm Sodium standard 500 mL

A metabolically stable adenosine analog that binds to adenosine A1, A2A, and A3 receptors with Ki values of 300, 80, and 1,900 nM, respectively anticonvulsive activity in a rat model of generalized seizures.

A metabolically stable adenosine analog that binds to adenosine A1, A2A, and A3 receptors with Ki values of 300, 80, and 1,900 nM, respectively anticonvulsive activity in a rat model of generalized seizures.

A metabolically stable adenosine analog that binds to adenosine A1, A2A, and A3 receptors with Ki values of 300, 80, and 1,900 nM, respectively anticonvulsive activity in a rat model of generalized seizures.

3-(4-Hydroxyphenyl)-1-propanol was used in the synthesis of (?)-centrolobine.

A specific adenosine A2 receptor agonist with antipyretic and anticonvulsant activity stimulates the production of cyclic AMP in CHO-K1 cells with an EC₅₀ value of 5.3 &microM.

A specific adenosine A2 receptor agonist with antipyretic and anticonvulsant activity stimulates the production of cyclic AMP in CHO-K1 cells with an EC₅₀ value of 5.3 &microM.

Application Sodium chloride solution has been used as a component of 10× binding buffer for glutamate carboxypeptidase II (NAALADase) assay.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

SpO2 Module (US Only)